Drug Research
Merck and BioNTech to boost lipid supply for Covid-19 vaccine production
Merck and BioNTech have announced a further expansion of their strategic partnership to accelerate the supply of urgently needed lipids and boost the amount of their delivery by the year-end.
The lipids will be used for producing the Pfizer and...
Drug Research
GSK and CureVac to develop next generation mRNA COVID-19 vaccines
GlaxoSmithKline plc and CureVac N.V. announced a new €150m collaboration, building on their existing relationship, to jointly develop next generation mRNA vaccines for COVID-19 with the potential for a multi-valent approach to address multiple emerging variants in one vaccine.
GSK...
Drug Research
Abzena selected to develop and manufacture antibody cocktail for Immunome’s COVID-19 Antibody Based Treatment
Immunome, Inc., a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, and Abzena, a partner research organization for integrated discovery to cGMP manufacturing solutions for biologics, today announced that Abzena...
Drug Research
Humanetics receives US DoD funding for Covid-19 drug development
Humanetics has received funding from the US Department of Defense (DoD) to carry out a series of studies with its novel drug candidate, BIO 300, for Covid-19.
The US DoD researchers discovered the drug candidate to create radio-protective drugs for...
Drug Research
X-Chem Acquires IntelliSyn and Sister Company, AviSyn, to Extend and Streamline Drug Discovery Service Range
X-Chem, Inc. (X-Chem), the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services, has acquired IntelliSyn, a Montreal-based drug discovery services company and its US-based sister company, AviSyn. The transaction will enable the Company to offer a complete, seamless solution...
Drug Research
BioMed X Institute starts new research project in drug delivery in collaboration with Janssen
German independent research institute BioMed X announces its new research project with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, which will strive to discover novel transport mechanisms in the human intestinal...
Drug Research
Enara and Boehringer Ingelheim sign oncology partnership
Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against overlooked dark antigen targets. How could dark antigens improve the treatment of solid tumour cancers.
UK-based Enara Bio has entered into a collaboration with German-headquartered...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
